key: cord-0727308-j8liyzcu authors: Trimpert, Jakob; Vladimirova, Daria; Dietert, Kristina; Abdelgawad, Azza; Kunec, Dusan; Dökel, Simon; Voss, Anne; Gruber, Achim D.; Bertzbach, Luca D.; Osterrieder, Nikolaus title: The Roborovski dwarf hamster – a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection date: 2020-11-19 journal: Cell Rep DOI: 10.1016/j.celrep.2020.108488 sha: 424babb4247e9d72a29c9a0aa33a9fdb64078da9 doc_id: 727308 cord_uid: j8liyzcu The COVID-19 pandemic caused by SARS-CoV-2 has precipitated an unprecedented and yet unresolved health crisis worldwide. Different mammals are susceptible to SARS-CoV-2; however, few species examined so far develop robust clinical disease that mirrors severe human cases or allows testing of vaccines and drugs under conditions of severe disease. Here, we compare the susceptibilities of three dwarf hamster species (Phodopus spp.) to SARS-CoV-2 and introduce the Roborovski dwarf hamster (P. roborovskii) as a highly susceptible COVID-19 model with consistent and fulminant clinical signs. Particularly, only this species shows SARS-CoV-2-induced severe acute diffuse alveolar damage and hyaline microthrombi in the lungs, changes described in patients who succumbed to the infection, but not reproduced in any experimentally infected animal. Based on our findings, we propose the Roborovski dwarf hamster as a valuable model to examine the efficacy and safety of vaccine candidates and therapeutics, particularly for use in highly susceptible individuals. The COVID-19 pandemic caused by SARS-CoV-2 has precipitated an unprecedented 25 and yet unresolved health crisis worldwide. Different mammals are susceptible to SARS- CoV-2 infection in three closely related yet genetically distinct dwarf hamster species of 73 the genus Phodopus. We observed striking differences in disease susceptibility between 74 these species, a phenomenon apparently independent of their ACE-2 sequence. All 75 residues shown to mediate interaction with the SARS-CoV-2 spike glycoprotein, which is 76 deemed the decisive factor for susceptibility to the infection (Ou et al., 2020) post-infection (dpi) to 33.1°C ± 1.1°C standard deviation (SD) at 2 dpi, and 30.2°C ± 97 0.4°C SD at 3 dpi ( Figure 1A) . Moreover, mean weight losses reached 14.35% ± 2.96% 98 SD (2 dpi) and 19.86% ± 2,68% SD on 3 dpi when compared to the mock-infected group 99 ( Figure 1D ). Roborovski dwarf hamsters also showed clear signs of clinical disease 100 including snuffling, dyspnea, and ruffled fur. Overall, the very active behavior otherwise 101 typical for this species was dramatically reduced. Three days after infection, multiple 102 individuals appeared to be terminally ill. For humane reasons, all infected Roborovski 103 dwarf hamsters were euthanized at this point. To investigate dose-dependency of the disease phenotype, we re-used three uninfected 105 animals intended as controls for the now obsolete later time points after infection. The 106 three remaining animals were infected with 5,000 pfu of SARS-CoV-2, a dose reduction 107 of 95% compared to the initial challenge. Weight loss observed in these hamsters was 108 only slightly delayed compared to the standard dose challenge; however, the decrease temperatures were observed in this species after infection, they proved to be highly We found significantly higher virus titers in the lungs of Roborovski dwarf hamster at 3 130 dpi when compared to the other two species (Figure 2A) . Notably, we detected viral RNA 131 copies of 2.06x10 6 ± 2.37x10 6 SD (2 dpi) and 1.81x10 6 ± 1.69x10 6 SD (3 dpi) in bucco- Figure 1D ). By virus titrations of the 136 blood collected from infected dwarf hamsters, we detected infectious virus at titers of 137 more than 100 pfu/ml blood in some but not all infected animals (Table S1 ). Finally, using RT-qPCR, we found less than 1,000 copies of virus RNA per 2.5 mg of 145 brain tissue, which suggests a lack of productive infection of the brain (Table S1 ). In extension of our initial trial, we infected three of the previously mock-infected Roborovski dwarf hamsters one week later with 5x10 3 pfu (in 20 µL volume) to test for (Table S3) . 559 Table S1 -SARS-CoV-2 blood titers and virus loads in brains of infected 560 Roborovski dwarf hamsters. The 567 proximal origin of SARS-CoV-2 The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice COVID-19: towards controlling of 572 a pandemic SARS-CoV-2 infection of Chinese hamsters 575 (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal 576 model Labs rush to study coronavirus in transgenic animals -some are in 578 short supply Simulation of the clinical and pathological 581 manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster 582 model: implications for disease pathogenesis and transmissibility Animal models of 585 mechanisms of SARS-CoV-2 infection and COVID-19 pathology Detection of 2019 novel 588 coronavirus (2019-nCoV) by real-time RT-PCR Age-dependent effects in the transmission and control of COVID-19 epidemics Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 594 in rhesus macaques Can ACE2 receptor 596 polymorphism predicts species susceptibility to SARS-CoV-2? A mouse-adapted 600 model of SARS-CoV-2 to test COVID-19 countermeasures An interactive web-based dashboard to track 602 COVID-19 in real time Phylogenetic network 604 analysis of SARS-CoV-2 genomes Standardization of Reporting Criteria for 607 Lung Pathology in SARS-CoV-2 Infected Hamsters -What Matters? Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse 611 model for vaccine efficacy Extrapulmonary 614 manifestations of COVID-19 A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies SARS-CoV-2 Cell 620 Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease 621 Inhibitor Syrian hamsters as a small 624 animal model for SARS-CoV-2 infection and countermeasure development Pathogenesis of SARS-CoV-2 in Transgenic Mice 628 Expressing Human Angiotensin-Converting Enzyme 2 Infection and Rapid Transmission of SARS-631 CoV-2 in Ferrets Spike mutation pipeline reveals the emergence of a more 633 transmissible form of SARS-CoV-2 A therapeutic non-self-reactive 636 SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model Hamsters The search for a COVID-19 animal 641 model Structure of the SARS-CoV-2 spike receptor-binding domain bound to 644 the ACE2 receptor Silico Analysis of Intermediate Hosts and Susceptible 647 Animals of SARS-CoV-2. ChemRxiv Characterisation of animal angiotensin-converting enzyme 2 receptors and use of 650 pseudotyped virus to correlate receptor binding with susceptibility of SARS-CoV 651 infection On the origin and continuing evolution of SARS-CoV-2. National 654 Comparison of SARS-CoV-2 infections among 3 species of non-657 human primates Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia Neural Androgen Synthesis and 662 Aggression: Insights From a Seasonally Breeding Rodent Effects of a mixture of medetomidine, 666 midazolam and butorphanol on anesthesia and blood biochemistry and the antagonizing 667 action of atipamezole in hamsters Age-Dependent 670 Progression of SARS-CoV-2 Infection in Syrian Hamsters Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its 673 immune cross-reactivity with SARS-CoV Variants Indicate Potential SARS-CoV-2-Susceptibility in Animals: An Extensive 676 Molecular Dynamics Study. bioRxiv Coronavirus Infections-More Than 678 Just the Common Cold SARS-CoV-2 is transmitted via contact and via the air between ferrets Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate 686 model Endocrine mechanisms of seasonal adaptation 688 in small mammals: from early results to present understanding Structural basis of receptor recognition by SARS-CoV-2 Susceptibility of ferrets, cats, dogs, and other domesticated animals 694 to SARS-coronavirus 2 Pathogenesis and transmission 697 of SARS-CoV-2 in golden hamsters Generation of a Broadly Useful Model for COVID-19 The trinity of 702 COVID-19: immunity, inflammation and intervention Receptor Recognition by 704 the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural 705 Studies of SARS Coronavirus Autopsy Findings 708 and Venous Thromboembolism in Patients With COVID-19 SARS-CoV-2 infection of human 712 ACE2-transgenic mice causes severe lung inflammation and impaired function Virological assessment 716 of hospitalized patients with COVID-2019 Age-related rhesus macaque models of COVID-19 Animal models for emerging 721 coronavirus: progress and new insights Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors 724 from human, pets, farm animals, and putative intermediate hosts